← Open Payments lookup

KENDALL BOLTE: Open Payments

NPI 1215348388 · YORK, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$414 in 26 payments from 11 companies in 2025. Trend: 2023 $529 · 2024 $461 · 2025 $414

Food & beverage: $414
CompanyPaymentsAmount
ABBVIE INC.11$154
Lilly USA, LLC4$61
Novo Nordisk Inc2$35
Astellas Pharma US Inc1$34
Bayer Healthcare Pharmaceuticals Inc.2$29
Otsuka America Pharmaceutical, Inc.1$22
E.R. Squibb & Sons, L.L.C.1$19
Seqirus USA Inc1$19
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$15
GlaxoSmithKline, LLC.1$14

Products named: VRAYLAR, MOUNJARO, QULIPTA, Ozempic, Veozah, UBRELVY, Kerendia, REXULTI.

Industry payments across NE — which companies pay providers there.